Alcohol and Alcoholism Advance Access originally published online on December 15, 2006
Alcohol and Alcoholism 2007 42(2):158-160; doi:10.1093/alcalc/agl091
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASE REPORT
SUPPRESSION OF SYMPTOMS OF ALCOHOL DEPENDENCE AND CRAVING USING HIGH-DOSE BACLOFEN
No. 207, 5340 Plymouth Road Ann Arbor, MI 48105, USA
*E-mail: wbucknam{at}hotmail.com
Received 14 July 2006; in revised form 8 August 2006; in revised form 18 August 2006; accepted 5 September 2006
| Abstract |
|---|
Aims: To further test whether the baclofen-induced suppression of motivation to consume alcohol in animals could be transposed to humans. Methods: A patient who had neither tolerated nor benefited from other alcohol treatment modalities was put on trial with baclofen on a dosage up to 140 mg/day. Results: The patient reported dramatic reduction in cravings for and preoccupation with alcohol. Conclusions: High-dose baclofen therapy was associated with complete and prolonged suppression of symptoms and consequences of alcohol-dependence.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Ameisen Gamma-Hydroxybutyrate (GHB)-Deficiency in alcohol-dependence? Alcohol Alcohol., September 1, 2007; 42(5): 506 - 506. [Full Text] [PDF] |
||||
